Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1-LV/5FU vs UFT in Colon Cancer
NCT00195585Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2002
- Primary completion
- Feb 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of levoleucovorin in colon cancer, sponsored by Pfizer. Started Oct 2002; status: completed.
02
Drugs
levoleucovorin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00195585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195585.